Passive avoidance learning (PAL) test was performed following 30 day treatment period with saline (C) and saline + polyherbal formulation (C+P) to control groupsand with streptozotocin and streptozotocin + polyherbal formulation (D+P) for diabetic groups.
A. Graph represents step-through latency in the acquisition trial (STL-a) of passive avoidance learning (PAL) task in the control and diabetic groups. Columns representMean ± SEM of step-through latency time (s).
B. Graph represents number of trials to acquisition of passive avoidance learning (PAL) task in the control and diabetic groups. Columns represent mean ± SEM.
Tukey’s multiple comparison tests was done to compare values between groups. *** indicates P<0.001, ** indicates P<0.01, * indicates P<0.05 and ns indicatesP>0.05. # indicates comparison of all groups with control group C.
